KALA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
KALA BIO Inc is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows weak technical indicators, poor financial performance, insider selling trends, and no significant positive catalysts to support a long-term growth outlook. It is better to avoid this stock at this time.
The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 23.298, providing no clear signal. Moving averages are bearish, with SMA_200 > SMA_20 > SMA_5. The stock is trading below its pivot level of 0.197, with key support at 0.157 and resistance at 0.237. Overall, the technical indicators suggest a bearish trend.
NULL identified. No recent news or significant positive developments.
Insiders are selling, with a 177.30% increase in selling activity over the last month. Financial performance is weak, with declining net income and EPS. No recent congress trading data or influential figure activity to indicate confidence in the stock.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped to -$7,564,000, a decline of -15.49% YoY. EPS fell to -1.07, down -44.56% YoY. Gross margin remained at 0 with no improvement. Overall, the financials indicate poor performance and no growth trends.
No specific analyst ratings or price targets for KALA BIO Inc. Recent analyst activity is focused on Cullinan Therapeutics, which is unrelated to KALA.
